Aimovig (erenumab)

675.002,025.00

Aimovig (erenumab) is a medication used for the treatment to help prevent migraines in adults.

DISEASE INDICATIONS

Migraine

MANUFACTURER

Amgen Inc.

Novartis Pharmaceuticals Corporation

USAGE

Subcutaneous

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

  • Health Canada

  • Pharmaceuticals and Medical Devices Agency (PMDA)

  • Therapeutic Goods Administration (TGA)

  • Swissmedic (CH)

  • Medsafe (NZ)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

    WE CAN HELP WITH YOUR IMPORT DOCUMENTS

    We are experts in import regulations.

This content has been reviewed by a Medical Doctor.
AIMOVIG (ERENUMAB) Package

1 Autoinjector(s) of 70mg/mL, 3 Autoinjector(s) of 70mg/mL, 1 Autoinjector(s) of 140mg/mL, 3 Autoinjector(s) of 140mg/mL

Reviews

There are no reviews yet.

Be the first to review “Aimovig (erenumab)”

Your email address will not be published. Required fields are marked *

Shopping Cart